Clinical Trial Manager — Phase I–IV Operations

Discover International; High Wycombe; On-site; GBP 65,000 - 90,000; Full time

Job summary

Discover International is seeking a Clinical Trial Manager to lead the operational delivery of Phase I–IV trials for pharmaceutical and biotech sponsors, guiding cross-functional teams from start-up through close-out.

You will ensure ICH-GCP compliance, manage budgets and vendors, mentor junior staff, and drive risk-based monitoring for oncology, rare disease, or cardiovascular trials.

Qualifications

• Life sciences degree or equivalent experience.
• 4+ years in clinical trial management within CRO/pharma/biotech.
• Proven line management and mentoring experience.
• Strong knowledge of ICH-GCP and UK/EU trial regulations.
• Experience managing study budgets and vendors.
• Experience in oncology, rare disease, or cardiovascular trials.

Responsibilities

• Own end-to-end trial management for assigned studies, ensuring delivery on time, on budget, and to quality standards.
• Line-manage CRAs/CRCs, overseeing site monitoring plans and performance.
• Serve as primary point of contact for sponsors, providing status updates and risk escalation.
• Develop and manage study budgets, timelines, and vendor/CRO oversight plans.
• Ensure inspection readiness and compliance with ICH-GCP, MHRA, and sponsor SOPs.
• Lead site selection, feasibility assessments, and study start-up activities.
• Chair internal and sponsor study team meetings.

Skills

People management

Budget management

Vendor management

ICH-GCP knowledge

Risk-based monitoring

Cross-functional collaboration

Education

Life sciences degree

Job description

Discover International is seeking a Clinical Trial Manager to lead the operational delivery of Phase I–IV trials for pharmaceutical and biotech sponsors, guiding cross-functional teams from start-up through close-out.

You will ensure ICH-GCP compliance, manage budgets and vendors, mentor junior staff, and drive risk-based monitoring for oncology, rare disease, or cardiovascular trials.